CV Sciences (CVSI) Receivables (2013 - 2026)
CV Sciences' (CVSI) quarterly Receivables came in at $391000.0 in Q1 2026, down 9.07% year-on-year from $430000.0 in Q1 2025, and down 2.74% quarter-over-quarter from $402000.0 in Q4 2025.
CV Sciences (CVSI) Receivables (2013 - 2026) Analysis & Trends
CV Sciences has disclosed Receivables across 14 years of filings, most recently posting $391000.0 for Q1 2026.
- Receivables for Q1 2026 came in at $391000.0, down 9.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $391000.0 (down 9.07% YoY), and the FY2025 annual result was $402000.0, down 22.99% from the prior year.
- Receivables came in at $391000.0 for Q1 2026 at CV Sciences, down from $402000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $7.4 million in Q2 2022 to a low of $391000.0 in Q1 2026.
- The 5-year median for Receivables is $545000.0 (2025), against an average of $2.5 million.
- Across the five-year window, Receivables soared 206.11% in 2022 and slumped 93.99% in 2023, its largest moves.
- CV Sciences' Receivables stood at $7.2 million in 2022, then plunged by 93.99% to $431000.0 in 2023, then advanced by 21.11% to $522000.0 in 2024, then fell by 22.99% to $402000.0 in 2025, then slipped by 2.74% to $391000.0 in 2026.
- The last three Receivables figures came in at $391000.0 (Q1 2026), $402000.0 (Q4 2025), and $405000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.51 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 312.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 31.29 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 768.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.15 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 407.63 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 149.62 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 355.67 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | 391,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 391,000.00 |
| Dec 31, 2025 | 402,000.00 |
| Sep 30, 2025 | 405,000.00 |
| Jun 30, 2025 | 545,000.00 |
| Mar 31, 2025 | 430,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 422,000.00 |
| Jun 30, 2024 | 639,000.00 |
| Mar 31, 2024 | 507,000.00 |
| Dec 31, 2023 | 431,000.00 |
| Sep 30, 2023 | 666,000.00 |
| Jun 30, 2023 | 611,000.00 |
| Mar 31, 2023 | 7.06 Mn |
| Dec 31, 2022 | 7.17 Mn |
| Sep 30, 2022 | 7.10 Mn |
| Jun 30, 2022 | 7.35 Mn |
| Mar 31, 2022 | 7.33 Mn |
| Dec 31, 2021 | 2.34 Mn |
| Sep 30, 2021 | 8.16 Mn |
| Jun 30, 2021 | 7.52 Mn |